In patients with COPD both with or without heart failure, AF episodes rise around the time patients are hospitalized for ...

Columnist Caroline Gainer is concerned about a couple of results from her recent annual wellness visit that could suggest ...

Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of ...

Medically reviewed by Kashif J. Piracha, MD Medically reviewed by Kashif J. Piracha, MD Acute kidney failure, now known as ...

The following is a summary of “Clinical Effectiveness and Safety of Dupilumab in Chronic Obstructive Pulmonary Disease ...

Long COVID development may be influenced by severity of the initial COVID-19 illness and pre-existing respiratory conditions, including COPD and OSA.

Guideline recommendations for acute pulmonary embolism (PE) developed by prominent professional societies give a mixed bag of advice across the US and Europe, according to a paper published online ...

Mechanical thrombectomy was associated with better survival outcomes across patient risk categories and time-to-treatment.

A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD.

Krunal Patel, MD, Temple University Hospital, highlights CHEST 2024 data revealing why timing matters with acute pulmonary embolism (PE) intervention.

Long COVID occurs in approximately a third of COVID-19 survivors, with the CDC estimating one in 13 adults in the United ...

Study reveals that COVID-19 significantly increases the risk of chronic fatigue syndrome, with specific populations, such as ...